Quick answers
- What is Tridacaine III?
- Tridacaine III is a brand name of Lidocaine, a prescription medicine. The FDA NDC Directory lists 1 Tridacaine III product in 1 strength and form.
- Who makes Tridacaine III?
- Ibsa holds the FDA application for Tridacaine III (ANDA209190, approved April 30, 2020).
- Is there a generic or store brand of Tridacaine III?
- Yes. The FDA NDC Directory lists 36 other products with the same active ingredients, strength and form as a Tridacaine III product, 36 of them generic. Ask your pharmacist whether one is right for you.
- Has Tridacaine III been recalled?
- No recall linked to Tridacaine III products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Tridacaine III is
Each Tridacaine III product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lidocaine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lidocaine 5% patch (topical) | Tridacaine III | 36 products, 20 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lidocaine →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA209190 | Ibsa | April 30, 2020 | 1 |
Companies that list Tridacaine III
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Tridacaine III products.
- Trifluent Pharma LLC1 product
Recalls
No recall linked to Tridacaine III products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.